Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fisgin, T.
Right arrow Articles by Akgün, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fisgin, T.
Right arrow Articles by Akgün, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Nasal Midazolam Effects on Childhood Acute Seizures

Tune Fisgin, MD

Department of Pediatric Hematology, fisgint{at}ato.org.tr

Yavuz Gürer, MD

Department of Pediatric Neurology

Nesrin Senbil, MD

Department of Pediatric Neurology

Tahsin Teziç, MD

Department of Pediatric Endocrinology

Pelin Zorlu, MD

Department of Pediatrics Dr. Sami Ulus Child Health and Disease Center Ankara, Turkey

Çetin Okuyaz, MD

Department of Pediatrics Dr. Sami Ulus Child Health and Disease Center Ankara, Turkey

Deniz Akgün, MD

Department of Pediatrics Dr. Sami Ulus Child Health and Disease Center Ankara, Turkey

Sixteen children, aged from 2 months to 14 years, with a diagnosis of acute seizures and seen at Dr. Sami Ulus Child Health and Disease Center, were included in this study. Midazolam (5 mg/mL) 0.2 mg/kg was administered intranasally in 30 seconds by an injector. The heart rate, respiratory rate, blood pressure, and oxygen saturation were recorded at 0, 5, and 10 minutes after administration. The seizures of three (18.7%) patients terminated within 1 minute, of seven (43.7%) patients in 1 to 2 minutes, and of three (18.7%) patients in 2 to 5 minutes. However, three (18.7%) patients did not respond to treatment. As a result, it was concluded that intranasal midazolam administration is easy and effective. The half-life of midazolam is shorter than diazepam, and midazolam has fewer complications when compared with diazepam. It is easier to use in nasal drop and spray forms. (J Child Neurol 2000;15:833-835).

Journal of Child Neurology, Vol. 15, No. 12, 833-835 (2000)
DOI: 10.1177/088307380001501219


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Child NeurolHome page
T. Fisgin, Y. Gurer, T. Tezic, N. Senbil, P. Zorlu, C. Okuyaz, and D. Akgun
Effects of Intranasal Midazolam and Rectal Diazepam on Acute Convulsions in Children: Prospective Randomized Study
J Child Neurol, February 1, 2002; 17(2): 123 - 126.
[Abstract] [PDF]